Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators

Transfus Apher Sci. 2004 Apr;30(2):131-6. doi: 10.1016/j.transci.2003.10.007.

Abstract

The authors compared the efficiency of two different blood cell separators (Amicus and Cobe-Spectra) in collecting peripheral blood progenitor cells for autologous or homologous transplantation. A total number of 129 procedures were performed, 36 with Spectra, 93 with Amicus. There was no difference between Spectra and Amicus efficiencies for CD34+ cell collection (46.685% vs 46.235%; p=n.s) but the platelet efficiencies were 17.31% and 12.54% respectively (p=0.04) and, if autologous and allogeneic collections were considered separately, a marked difference resulted in allogeneic platelet efficiency between 6 Spectra and 23 Amicus procedures (26.83% vs 8.68%, p=0.0004). The authors were able to demonstrate that in 70 Amicus autologous collections there was a different platelet efficiency, if peripheral count was considered: 12 procedures performed with a platelet count > 100 x 10(9)/l had a very low efficiency (6.86%), but this value increased if platelet count lowered (13.02% if between 100 and 50 x 10(9)/l, 22.63% if between 50 and 0 x 10(9)/l, 23 and 35 procedures respectively). The study is preliminary and the number of collections is little, but the overall data suggest that Spectra (AutoPBSC, V 6.0) and Amicus separators have the same efficiency for collecting CD34+ cells while Amicus procedures have a very low platelet contamination, especially with donors.

Publication types

  • Comparative Study

MeSH terms

  • Antigens, CD34 / biosynthesis
  • Antineoplastic Agents / therapeutic use
  • Blood Component Removal / instrumentation
  • Blood Component Removal / methods*
  • Blood Platelets / cytology
  • Cell Separation / instrumentation*
  • Cell Separation / methods*
  • Hodgkin Disease / drug therapy
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy
  • Multiple Myeloma / drug therapy
  • Platelet Count
  • Plateletpheresis
  • Stem Cells / immunology*
  • Transplantation, Autologous
  • Transplantation, Homologous

Substances

  • Antigens, CD34
  • Antineoplastic Agents